Pathology Doctors in Reading, PA Accepting Medicare

3 Pathology doctors found. Showing 1 - 3

Margaret L. Freeman, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 6th Ave And Spruce St, Reading, PA 19612 Phone: 610-988-8618

George Connerton, MD Pathology - Clinical Pathology/Laboratory Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 Bernville Rd, Box 316, Reading, PA 19605 Phone: 610-378-2200

Peter Christ, MD Pathology - Clinical Pathology/Laboratory Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Bernville Rd, Box 316, Reading, PA 19605 Phone: 610-378-2218

News Archive

Senators prepare to debate abortion treatment in Senate bill

The Associated Press: "Senators debating health care legislation are headed for a clash over abortion, the issue that threatened to derail the bill in the House. Anticipating the showdown, hundreds of abortion rights supporters gathered on Capitol Hill Wednesday to call on senators to keep new abortion restrictions out of the health care bill.

New Imperial College centre to tackle respiratory infections

Think that colds and flu are easy to catch, hard to avoid and impossible to treat? That nobody ever dies of a cold? That's all wrong, say the medics and scientists at a new research centre which launches today (Monday 2 June).

Effectiveness of VSEL stem cells in regenerative medicine demonstrated at the ASH meeting

NeoStem, Inc. (NYSE Amex: NBS), which is a leading provider of pre-disease adult stem cell collection, processing and long-term storage services, and holds the exclusive, worldwide license to VSEL(TM) technology that uses very small embryonic-like stem cells isolated from peripheral blood, announced today that five posters and two oral presentations at the prestigious American Society of Hematology (ASH) Annual Meeting in New Orleans in early December demonstrated the basic cellular mechanisms of very small embryonic-like stem cells.

CPEX Pharmaceuticals' Phase 2a Nasulin trial fails, Arcadia Capital Advisors issues statement

Richard S. Rofe, who serves as Managing Director for Arcadia Capital Advisors, LLC, and is part of a shareholder group that includes Arcadia with a 9.97 percent ownership interest in CPEX Pharmaceuticals, Inc.,, commented on CPEX's recent announcement of failed Phase 2a Nasulin study results.

Glucocorticoid steroids in intelligent medicine specifically hits relevant cells

Scientists at Aarhus University, Denmark in collaboration with the biotech company Cytoguide now publish a key to use glucocorticoid steroids in a kind of intelligent medicine that specifically hits the relevant cells. Data are based on rodent studies but if this principle is translated to humans it may greatly improve todays hazardous treatment with this type of potent steroids.

Read more Medical News

› Verified 4 days ago